Whilst there appears to be no specific oxyntomodulin receptor, endogenous oxyntomodulin causes appetite suppression, increased energy expenditure, and weight loss in people with obesity via activation of GLP-1 and GCG receptors
One peptide with 10 cysteine residues, the sequence of which mimics that of the -domain of MT, binds the nanoparticles and a mass spectrometric analysis of the peptide-bound nanoparticles shows that it binds three cadmium ions released from the surface
However, given the progressive nature of PD, symptoms tend to worsen despite treatment, and over time, existing therapies begin to lose efficacy, even at increased doses
Some of these will be mild, like flatulence, cramping, or constipation, whilst others can be more severe